Pfizer Inc. announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas. Sunitinib more than doubled the time patients with pancreatic neuroendocrine tumors lived without disease progression compared with patients treated with [...]

Pfizer Inc. (NYSE: PFE) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, biologic for the treatment of Dupuytren’s contracture (a condition resulting in the contracture of the fingers into the palm), has completed [...]

GenVec, Inc. (Nasdaq: GNVC) announced that 184 events (deaths) have occurred in its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade™ (PACT) in patients with locally advanced pancreatic cancer. This event, which represents two-thirds of the total events expected in the trial, triggers the next interim analysis of overall survival in the trial. GenVec [...]

Bone chilling temperatures have gripped much of the country, and the American Red Cross urges everyone to be safe and prepare as much as possible.
Many are looking to cut down on expenses when temperatures drop and home-heating costs rise. “There is usually an increase in home fires at this time of year because of the [...]

AngioDynamics (NASDAQ:ANGO) announced the launch of a new family of micro-introducer kits, featuring a stiffened introducer option.
“Our broad range of kits gives physicians a comprehensive set of options to treat their patients and allows healthcare institutions to source all micro-introducer needs from a reliable and trusted provider.”